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ABSTRACT The spread of multidrug-resistant (MDR) tuberculosis (TB) has become a
major global challenge. In 2016, Tasmania recorded its ﬁrst known incidence of
MDR-TB. Here, we report the draft whole-genome sequence of the Mycobacterium
tuberculosis isolate from this case, TASMDR1, and describe single-nucleotide poly-
morphisms associated with its drug resistance.
The earliest written record of tuberculosis (TB) in Tasmania comes from ColonelDavid Collins, who reported in 1804 that a member of his Hobart settlement had
consumption (1). Today, Tasmania is regarded as a low-TB-burden state with an incidence
rate of 1.7/100,000 persons compared to 5.7/100,000 nationally in Australia in 2014 (2). Until
recently, Tasmania had been free of multidrug-resistant (MDR) forms of TB; however, in
2016 its ﬁrst case of MDR-TB was reported.
We have previously characterized the genomes of MDR and extensively drug-resistant
(XDR) Mycobacterium tuberculosis (3–5). Here, genomic DNA of the Tasmanian isolate,
TASMDR1, was sequenced using an Illumina MiSeq instrument. A total of 2,860,297
paired-end reads were mapped to the publicly available annotated genome of M. tu-
berculosis reference strain H37Rv (GenBank accession number NC_000962.3) (6) by
Burrows-Wheeler alignment (7). This yielded an average read depth of 65.5-fold,
covering 97.8% of the H37Rv genome. Variants relative to the H37Rv reference genome
were called using the SAMtools analysis suite, and variant annotation was performed
using SnpEff (8, 9). A 4,230,496-bp draft genome assembly of 220 contigs was assem-
bled de novo using the SPAdes assembler (v3.7) (10). Assembled contigs were ordered
with respect to the M. tuberculosis H37Rv genome using ABACAS (11).
A total of 1,553 variant sites were identiﬁed relative to the H37Rv genome and
consisted of 1,408 single-nucleotide variants (SNVs) and 145 insertions/deletions. Of the
variants, 881 were nonsynonymous; of these, 784 were SNVs and 97 were insertions/
deletions. The genome of TASMDR1 displayed high-conﬁdence single-nucleotide poly-
morphisms in genes correlating with antimicrobial drug resistance when analyzed
using the PhyResSE database (12). These include high-conﬁdence mutations in the katG
gene (aGc/aCc, S315T) and rpoB gene (gAc/gGc, D435G; tCg/tTg, S450L), which underlie
M. tuberculosis resistance to isoniazid and rifampin, respectively (13, 14). These data
establish the genetic bases of the MDR phenotype exhibited by strain TASMDR1.
Additional mutations were detected in the embB gene (Atg/Gtg, M306V) and pncA
gene (cCg/cTg, P62L) that are associated with resistance to ethambutol and pyrazin-
amide, respectively (15–18). Furthermore, an A/C substitution was detected at position
514 of the 16S rRNA gene, rrs (MTB000019), and is related to streptomycin resistance
(19, 20). The TASMDR1 isolate belongs to the Beijing sublineage of East Asian Lineage
2, as predicted by the PhyResSE and TB Proﬁler databases (12, 21).
The drug-resistance mutations that were identiﬁed in the genome of the TASMDR1
isolate were detected within a signiﬁcantly shorter turn-around time compared to
Received 29 September 2017 Accepted 2
October 2017 Published 2 November 2017
Citation Gautam SS, Mac Aogáin M, O’Toole
RF. 2017. Draft genome sequence of the ﬁrst
conﬁrmed isolate of multidrug-resistant
Mycobacterium tuberculosis in Tasmania.
Genome Announc 5:e01230-17. https://doi
.org/10.1128/genomeA.01230-17.
Copyright © 2017 Gautam et al. This is an
open-access article distributed under the terms
of the Creative Commons Attribution 4.0
International license.




Volume 5 Issue 44 e01230-17 genomea.asm.org 1
conventional phenotypic drug-susceptibility testing. Although MDR-TB isolates are
currently rare in Tasmania, this study highlights the utility of having a microbial
whole-genome sequencing facility available for rapidly determining the resistance
proﬁles of MDR-TB isolates that may present in a low-TB-incidence setting.
Accession number(s). This whole-genome shotgun project has been deposited at
DDBJ/ENA/GenBank under the accession number NTFG00000000. The version de-
scribed in this paper is version NTFG01000000.
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